46,477 research outputs found

    Reply to comments on 'EPR study of He-implanted Si' by P. Pivac, B. Rakvin, R. Tonini, F. Corni, G. Ottaizani, Published in Mater. Sci. Eng. B73 (2000) 60-63 - Written by M. Kakazey, M. Vlasova, and J.G. Gonzalez-Rodriguez - Reply to discussion

    No full text
    Reply to comments on 'EPR study of He-implanted Si' by P. Pivac, B. Rakvin, R. Tonini, F. Corni, G. Ottaizani, Published in Mater. Sci. Eng. B73 (2000) 60-63 - Written by M. Kakazey, M. Vlasova, and J.G. Gonzalez-Rodriguez - Reply to discussio

    SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders

    No full text
    The sialic-acid-binding immunoglobulin-like lectin SIGLEC-G is a negative regulator of B-cell receptor-mediated calcium signaling. Its deficiency leads to reduced turnover and increased proliferation and survival of murine B-1a cells. Siglecg-/- mice show a premature expansion of polyclonal CD5+ B cells in the spleen and the peritoneal cavity. Here we studied the fate of B lymphocytes in Siglecg-/- mice over time. We demonstrate that in aging animals SIGLEC-G deficiency promotes progressive accumulation of monoclonal B lymphocytes and increases the susceptibility to develop B-cell lymphoproliferative disorders. Lymphoid tumors arising in aged Siglecg-/- mice are monoclonal and histologically heterogeneous as they include diffuse large B-cell lymphoma, follicular lymphoma, and medium-to-large B-cell monomorphic lymphoma but surprisingly not chronic lymphocytic leukemia. The tumors express high levels of BCL-2 and are transplantable. In keeping with these findings we have also observed a remarkable down-regulation of the human ortholog SIGLEC10 in human B-cell lymphoma and leukemia cell lines. Taken together, these observations indicate that the down-regulation of negative B-cell receptor regulators such as SIGLEC-G/SIGLEC10 may represent another mechanism relevant to the pathogenesis of B-cell lymphomas. © 2014 Ferrata Storti Foundation

    Observations of Bºs→ψ(2S)η and Bº(s)→ψ(2S)π+π- decays

    No full text
    First observations of the B0s →ψ(2S)η, B0 →ψ(2S)π + π − and B0s →ψ(2S)π + π − decays are made using a dataset corresponding to an integrated luminosity of 1.0 fb−1 collected by the LHCb experiment in proton–proton collisions at a centre-of-mass energy of √ s = 7 TeV. The ratios of the branching fractions of each of the ψ(2S) modes with respect to the corresponding J/ψ decays are B(B0s →ψ(2S)η) ÷ B(B0s →J/ψη) = 0.83± 0.14 (stat)±0.12 (syst) ±0.02 (B), ; B(B0→ψ(2S)π + π − ) ÷ B(B0→J/ψπ + π − ) = 0.56± 0.07 (stat)±0.05 (syst)± 0.01 (B), ; B(B0s →ψ(2S)π + π − ) ÷ B(B0s →J/ψπ + π − ) = 0.34± 0.04 (stat)±0.03 (syst)± 0.01 (B), where the third uncertainty corresponds to the uncertainties of the dilepton branching fractions of the J/ψ and ψ(2S) meson decays

    Father Reyes Rodriguez, Hispanic Oral Histories, Accn 1369

    No full text
    Father Rodriguez (b. 1934) talks about his family roots in Mexico, the marriage of his parents and their life in Layton, Utah, and his childhood. Other topics include home remedies, cooking, traditional hispanic family life, religion, his church service, entering the seminary at the age of 25, the psychological impact of his training, Catholicism, a memorable sermon, and life as a Catholic priest. Interviewed by Leslie Kelen, 117 pages

    Measurement of the ratio of branching fractions B(B0→K∗0γ )/B(B0s→φγ ) and the directCP asymmetry inB 0→K∗0γ

    No full text
    The ratio of branching fractions of the radiative B decays B0→K⁎0γ and B0s→ϕγ has been measured using an integrated luminosity of 1.0 fb−1 of pp collision data collected by the LHCb experiment at a centre-of-mass energy of s√=7TeV. The value obtained is B(B0→K⁎0γ)B(B0s→ϕγ)=1.23±0.06(stat.)±0.04(syst.)±0.10(fs/fd), where the first uncertainty is statistical, the second is the experimental systematic uncertainty and the third is associated with the ratio of fragmentation fractions fs/fd. Using the world average value for B(B0→K⁎0γ), the branching fraction B(B0s→ϕγ) is measured to be (3.5±0.4)×10−5. The direct CP asymmetry in B0→K⁎0γ decays has also been measured with the same data and found to be ACP(B0→K⁎0γ)=(0.8±1.7(stat.)±0.9(syst.))%. Both measurements are the most precise to date and are in agreement with the previous experimental results and theoretical expectations

    SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders

    No full text
    The sialic-acid-binding immunoglobulin-like lectin SIGLEC-G is a negative regulator of B-cell receptor-mediated calcium signaling. Its deficiency leads to reduced turnover and increased proliferation and survival of murine B-1a cells. Siglecg-/- mice show a premature expansion of polyclonal CD5+ B cells in the spleen and the peritoneal cavity. Here we studied the fate of B lymphocytes in Siglecg-/- mice over time. We demonstrate that in aging animals SIGLEC-G deficiency promotes progressive accumulation of monoclonal B lymphocytes and increases the susceptibility to develop B-cell lymphoproliferative disorders. Lymphoid tumors arising in aged Siglecg-/- mice are monoclonal and histologically heterogeneous as they include diffuse large B-cell lymphoma, follicular lymphoma, and medium-to-large B-cell monomorphic lymphoma but surprisingly not chronic lymphocytic leukemia. The tumors express high levels of BCL-2 and are transplantable. In keeping with these findings we have also observed a remarkable down-regulation of the human ortholog SIGLEC10 in human B-cell lymphoma and leukemia cell lines. Taken together, these observations indicate that the down-regulation of negative B-cell receptor regulators such as SIGLEC-G/SIGLEC10 may represent another mechanism relevant to the pathogenesis of B-cell lymphomas

    The clock diet: a practical nutritional guide to manage obesity through chrononutrition

    No full text
    Chronobiology studies the biological rhythms or circadian cycles of living organisms and their adaptation to external changes. Biological rhythms can affect hormone production cycles such as sleep/wake, and nutrition/fasting, but these factors can also alter the circadian rhythm (CR). In recent years, numerous studies have highlighted how feeding times and frequency can influence biological rhythms. Additionally, individuals’ chronotype, working shifts, and food intake can make a deep impact on people’s tendency to develop obesity and metabolic diseases. In this context, a single food and a specific combination of these, can also affect the CR and fasting cycle and consequently body weight and viceversa. The purpose of the review is to propose practical nutritional recommendations to help in resynchronizing the circadian rhythm as a tool in weight control. (Cite this article as: Barrea L, Frias-Toral E, Aprano S, Castellucci B, Pugliese G, Rodriguez-Veintimilla D, et al. The clock diet: a practical nutritional guide to manage obesity through chrononutrition. Minerva Med 2022;113:172-88. DOI: 10.23736/ S0026-4806.21.07207-4

    Complete 1H and 13C NMR assignments of clerodane diterpenoids of Salvia splendens

    No full text
    Unambiguous and complete assignments of 1H and 13C NMR chemical shifts for five clerodane diterpenes, four of them isolated from Salvia splendens (salviarin, splendidin and splenolides A and B) and one obtained by acetylation of splenolide A, are presented. The assignments are based on 2D shiftcorrelated [1H,1H–COSY, 1H,13C-gHSQC–1J(C,H) and 1H,13C-gHMBC-nJ(C,H) (n = 2 and 3)] and nuclear Overhauser effect (NOE) experiments. The conformation of the rings of these compounds is supported by the 3J(H,H) values and NOE results. Copyright 2006 John Wiley & Sons, Lt

    Clerodane Diterpenoids from Salvia splendens

    No full text
    Four new clerodane diterpenoids, salvisplendins A-D (1-4), have been isolated from an acetone extract of the flowers of SalVia splendens, together with an artifact (5), arising from salvisplendin D (4) by addition of diazomethane, and the already known clerodane olearin (6). The structures of the new compounds (1-5) were established mainly by 1D and 2D NMR spectroscopic studies and, in the case of salvisplendin A (1), by chemical correlation with splenolide B (7). Complete 1H and 13C NMR assignments for olearin (6), not published hitherto, are also reported

    Anonymization and Secrey in Supervision Processes – a Methodological, Ethical, Clinical and Legal Problem

    No full text
    Aus rechtlichen, ethischen und supervisionsmethodischen Gründen müssen PatientInnen/KlientInnen um Zustimmung gefragt werden, ob ihr Prozess in der Supervision thematisiert werden darf. Trotz eines obergerichtlichen Urteils in dieser Sache, wird – wie die Forschung bis in die neuste Zeit in bedauerlicher Weise zeigt – diese strafbewehrte Rechtsvorschrift von SupervisorInnen immer wieder verletzt (vgl. Petzold et al. 2017 Transparenzdilemma; Collenberg 2017). Dieser Text von 1996 – mehrfach aus gegebenen Anlässen wieder neu publiziert – wird mit seinen grundsätzlichen Argumentationen deshalb hier neu eingestellt. Zusammen mit anderen Arbeiten, die in dieser Zeitschrift zu „prekärer Supervision“ publiziert worden sind (z. B. 1, 2 und 7/2016; 5/2017; 4/2012), wird das für uns eine Thema der Qualitätssicherung in einem Bereich der Qualitätsdefizite und -schwächen von Supervision bleiben, dem unsere Aufmerksamkeit gilt (vgl. 2/2018, 3/2018).Because of legal grounds, ethical reasons and arguments from supervisory methodology patients/clients have to be asked for consent, that their process material can become a topic in supervision. Although there is a superior court decision concerning this issue, empirical research is showing to our regret that this punishable regulation is violated by supervisors again and again (vgl. Petzold et al. 2017 dilemma of transparency; Collenberg 2017). This text from 1996 – which has been published for good reasons several times anew – is posted here again with its fundamental arguments together with some more studies concerning precarious supervision. Together with other articles that have been published in this Journal concerning „precarious supervision“ (e.g. 1, 2 und 7/2016; 5/2017; 4/2012), this topic of quality assurance in an area of quality deficits and –weaknesses of supervision will stay a focus of our attention (cf. 2/2018, 3/2018).https://www.fpi-publikation.de/supervision/01-2018-petzold-h-g-rodriguez-petzold-f-1996-anonymisierung-schweigepflicht-ethisches/peerReviewedpublishedVersio
    corecore